UBS Adjusts Yixintang Pharmaceutical Group's Price Target to 35 Yuan From 51 Yuan, Keeps at Buy
UBS Adjusts Yixintang Pharmaceutical Group's Price Target to 35 Yuan From 51 Yuan, Keeps at Buy
瑞銀將一心堂藥業集團的目標股價從51元調整爲35元,維持買入
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊